Published in Diabetes Care on March 13, 2008
Artificial pancreas: past, present, future. Diabetes (2011) 3.03
Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol (2011) 2.44
Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther (2009) 2.12
Diabetes: Models, Signals, and Control. IEEE Rev Biomed Eng (2009) 2.11
A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care (2012) 1.97
Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol (2009) 1.63
Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol (2013) 1.62
Continuous glucose monitors prove highly accurate in critically ill children. Crit Care (2010) 1.40
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Evaluating the clinical accuracy of GlucoMen®Day: a novel microdialysis-based continuous glucose monitor. J Diabetes Sci Technol (2010) 1.32
A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther (2014) 1.27
Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol (2010) 1.22
Estimating plasma glucose from interstitial glucose: the issue of calibration algorithms in commercial continuous glucose monitoring devices. Sensors (Basel) (2010) 1.20
Function of an implanted tissue glucose sensor for more than 1 year in animals. Sci Transl Med (2010) 1.18
Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems. Diabetes Technol Ther (2012) 1.16
Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock. Diabetes Technol Ther (2012) 1.16
Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther (2012) 1.15
Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol (2009) 1.11
Biocompatible materials for continuous glucose monitoring devices. Chem Rev (2013) 1.10
DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. J Diabetes Sci Technol (2013) 1.09
Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study. Diabet Med (2010) 1.07
Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring. J Diabetes Sci Technol (2009) 1.07
Continuous glucose monitoring in the subcutaneous tissue over a 14-day sensor wear period. J Diabetes Sci Technol (2013) 1.05
Effects of moderate-to-vigorous intensity physical activity on overnight and next-day hypoglycemia in active adolescents with type 1 diabetes. Diabetes Care (2014) 1.05
Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life. J Diabetes Sci Technol (2013) 1.04
Robust fault detection system for insulin pump therapy using continuous glucose monitoring. J Diabetes Sci Technol (2012) 1.00
Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol (2010) 0.98
Measurement delay associated with the Guardian RT continuous glucose monitoring system. Diabet Med (2010) 0.97
A novel adaptive basal therapy based on the value and rate of change of blood glucose. J Diabetes Sci Technol (2009) 0.95
Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes. Scientifica (Cairo) (2012) 0.95
A bio-inspired glucose controller based on pancreatic β-cell physiology. J Diabetes Sci Technol (2012) 0.90
Continuous glucose monitoring: a review for behavioral researchers. Psychosom Med (2012) 0.88
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes (2011) 0.88
Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept. Diabetes Technol Ther (2012) 0.87
Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol (2013) 0.87
A standard approach to continuous glucose monitor data in pregnancy for the study of fetal growth and infant outcomes. Diabetes Technol Ther (2012) 0.86
Sources of glycemic variability--what type of technology is needed? J Diabetes Sci Technol (2009) 0.86
Accuracy performance of the Medtronic NexSensor™ for 6 days in an inpatient setting using abdomen and buttocks insertion sites. J Diabetes Sci Technol (2011) 0.85
Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes (2011) 0.85
A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial. J Diabetes Sci Technol (2013) 0.84
Clinical requirements for closed-loop control systems. J Diabetes Sci Technol (2012) 0.82
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference. J Diabetes Sci Technol (2016) 0.82
Sensor Monitoring of Physical Activity to Improve Glucose Management in Diabetic Patients: A Review. Sensors (Basel) (2016) 0.82
Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detection. J Diabetes Sci Technol (2013) 0.82
Fitting dynamic models with forcing functions: application to continuous glucose monitoring in insulin therapy. Stat Med (2011) 0.82
Role of vascular networks in extending glucose sensor function: Impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo. J Biomed Mater Res A (2013) 0.81
Comparison between one-point calibration and two-point calibration approaches in a continuous glucose monitoring algorithm. J Diabetes Sci Technol (2014) 0.80
Real-time glucose estimation algorithm for continuous glucose monitoring using autoregressive models. J Diabetes Sci Technol (2010) 0.80
Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Children with Type 1 Diabetes- Are there Pros and Cons for Both? US Endocrinol (2012) 0.79
Continuous glucose monitoring system: Is it really accurate, safe and clinically useful? J Diabetes Investig (2012) 0.78
Accuracy of a Novel Noninvasive Multisensor Technology to Estimate Glucose in Diabetic Subjects During Dynamic Conditions. J Diabetes Sci Technol (2014) 0.78
Continuous Glucose Monitoring: Impact on Hypoglycemia. J Diabetes Sci Technol (2016) 0.78
Performance Comparison of CGM Systems: MARD Values Are Not Always a Reliable Indicator of CGM System Accuracy. J Diabetes Sci Technol (2015) 0.78
Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes. Int J Endocrinol (2013) 0.77
Impact of glucose measurement processing delays on clinical accuracy and relevance. J Diabetes Sci Technol (2013) 0.76
Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia. BMC Endocr Disord (2015) 0.76
The accuracy of a new real-time continuous glucose monitoring algorithm: an analysis. J Diabetes Sci Technol (2010) 0.76
Comparison of the numerical and clinical accuracy of four continuous glucose monitors: response to Kovatchev et al. Diabetes Care (2008) 0.76
Signal processing algorithms implementing the "smart sensor" concept to improve continuous glucose monitoring in diabetes. J Diabetes Sci Technol (2013) 0.76
How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus? Nat Clin Pract Endocrinol Metab (2009) 0.75
In silico evaluation of a control system and algorithm for automated insulin infusion in the ICU setting. Biomed Eng Online (2010) 0.75
Pilot study of a prototype minimally invasive intradermal continuous glucose monitor. J Diabetes Sci Technol (2012) 0.75
Continuous glucose monitoring in pregnancy: new frontiers in clinical applications and research. J Diabetes Sci Technol (2012) 0.75
Evaluation of accuracy of ambulatory glucose profile in an outpatient setting in children with type 1 diabetes. Indian J Endocrinol Metab (2016) 0.75
Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing. J Diabetes Sci Technol (2016) 0.75
Use of microdialysis-based continuous glucose monitoring to drive real-time semi-closed-loop insulin infusion. J Diabetes Sci Technol (2014) 0.75
Continuous Glucose Monitoring in Patients with Abnormal Glucose Tolerance during Pregnancy: A Case Series. Jpn Clin Med (2016) 0.75
Effect of Peripheral Electrical Stimulation (PES) on Nocturnal Blood Glucose in Type 2 Diabetes: A Randomized Crossover Pilot Study. PLoS One (2016) 0.75
Use of sensors in the treatment and follow-up of patients with diabetes mellitus. Sensors (Basel) (2010) 0.75
Continuous glucose monitoring and trend accuracy: news about a trend compass. J Diabetes Sci Technol (2014) 0.75
Can technological solutions for diabetes replace islet cell function? Organogenesis (2011) 0.75
Significance and Reliability of MARD for the Accuracy of CGM Systems. J Diabetes Sci Technol (2016) 0.75
Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study. J Diabetes Sci Technol (2015) 0.75
The Quantitative Relationship Between ISO 15197 Accuracy Criteria and Mean Absolute Relative Difference (MARD) in the Evaluation of Analytical Performance of Self-Monitoring of Blood Glucose (SMBG) Systems. J Diabetes Sci Technol (2016) 0.75
Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: the COBIN2 study. Wien Klin Wochenschr (2014) 0.75
Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care (1988) 9.27
A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care (2000) 8.86
Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care (2004) 4.31
Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes (2003) 3.90
Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther (2005) 3.84
Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care (2003) 2.53
Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia (2005) 2.38
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care (2002) 1.92
Modeling of Calibration Effectiveness and Blood-to-Interstitial Glucose Dynamics as Potential Confounders of the Accuracy of Continuous Glucose Sensors during Hyperinsulinemic Clamp. J Diabetes Sci Technol (2007) 1.89
Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy. J Diabetes Sci Technol (2007) 1.61
Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther (2003) 1.56
Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technol Ther (2002) 1.54
A novel approach to mitigating the physiological lag between blood and interstitial fluid glucose measurements. Diabetes Technol Ther (2004) 1.45
Toward continuous glucose monitoring with planar modified biosensors and microdialysis. Study of temperature, oxygen dependence and in vivo experiment. Biosens Bioelectron (2006) 1.19
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes (2004) 3.66
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol (2010) 3.48
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care (2006) 3.08
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol (2009) 2.67
Alternative calibration strategies for the clinical laboratory: application to nortriptyline therapeutic drug monitoring. Clin Chem (2013) 2.64
Diabetes care in the school and day care setting. Diabetes Care (2012) 2.41
Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care (2003) 2.36
Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta (2007) 2.23
Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care (2005) 2.11
Opiate-positive immunoassay screen in a pediatric patient. Clin Chem (2010) 2.02
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther (2013) 1.71
Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis (2013) 1.64
Prediction of severe hypoglycemia. Diabetes Care (2007) 1.60
Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study. Pediatrics (2008) 1.54
Blood glucose meter market: this world is undergoing drastic changes. J Diabetes Sci Technol (2013) 1.51
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device. J Diabetes Sci Technol (2008) 1.46
Effect of nitrous oxide on neurologic and neuropsychological function after intracranial aneurysm surgery. Anesthesiology (2008) 1.46
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One (2013) 1.40
A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia (2014) 1.38
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Driving mishaps among individuals with type 1 diabetes: a prospective study. Diabetes Care (2009) 1.36
Hypoglycemia preceding fatal car collisions. Diabetes Care (2006) 1.36
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center. J Diabetes Sci Technol (2012) 1.35
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care (2013) 1.32
Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab (2007) 1.31
A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes (2010) 1.26
Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther (2003) 1.24
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther (2011) 1.21
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care (2005) 1.19
Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology. J Diabetes Sci Technol (2008) 1.17
Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther (2003) 1.16
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther (2011) 1.14
Comparison of modification sites formed on human serum albumin at various stages of glycation. Clin Chim Acta (2010) 1.14
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care (2005) 1.10
Receipt of diabetes services by insured adults with and without claims for mental disorders. Med Care (2004) 1.10
Effect of automated bio-behavioral feedback on the control of type 1 diabetes. Diabetes Care (2011) 1.09
Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin. Biosens Bioelectron (2009) 1.08
Biosimilar insulin and insulin antibodies. J Diabetes Sci Technol (2013) 1.08
Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis (2004) 1.08
Hypoglycemia warning signal and glucose sensors: requirements and concepts. Diabetes Technol Ther (2003) 1.08
Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents. Diabetes Manag (Lond) (2011) 1.05
Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. Clin Chim Acta (2011) 1.05
Rapid pain modulation with nuclear receptor ligands. Brain Res Rev (2008) 1.03
Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med (2004) 1.02
The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. Int J Clin Pract Suppl (2002) 1.02
Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol (2007) 1.00
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care (2010) 0.99
Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Care (2007) 0.99
Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta (2010) 0.98
Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther (2003) 0.98
Blood glucose awareness training delivered over the internet. Diabetes Care (2008) 0.98
Investigating interferences of a whole-blood point-of-care creatinine analyzer: comparison to plasma enzymatic and definitive creatinine methods in an acute-care setting. Clin Chem (2011) 0.97
Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure. Am J Cardiol (2011) 0.96
The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther (2009) 0.96
Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr (2010) 0.95
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy. Retrovirology (2011) 0.95
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr (2015) 0.94
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther (2014) 0.93
Evaluating clinical accuracy of continuous glucose monitoring systems: Continuous Glucose-Error Grid Analysis (CG-EGA). Curr Diabetes Rev (2008) 0.93
Neurocognitive Differences Between Drivers with Type 1 Diabetes with and without a Recent History of Recurrent Driving Mishaps. Int J Diabetes Mellit (2010) 0.93
Blood concentrations of chlorhexidine in hospitalized children undergoing daily chlorhexidine bathing. Infect Control Hosp Epidemiol (2011) 0.93
Care of children with diabetes in the school and day care setting. Diabetes Care (2003) 0.93
Analytical performance of 4 automated assays for measurement of cystatin C. Clin Chem (2010) 0.93
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin. J Diabetes Sci Technol (2008) 0.93
Improvements in the continuum of HIV care in an inner-city emergency department. AIDS (2016) 0.91
Assessing the analytical performance of systems for self-monitoring of blood glucose: concepts of performance evaluation and definition of metrological key terms. J Diabetes Sci Technol (2013) 0.90
Diabetes care in the school and day care setting. Diabetes Care (2004) 0.90
Low-level Viremia early in HIV infection. J Acquir Immune Defic Syndr (2014) 0.89
Percutaneous vertebroplasty for acute vertebral body fracture and deformity in multiple myeloma: a short report. Br J Haematol (2004) 0.89
Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care: response to Staten et al. Diabetes Care (2010) 0.89
Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors. J Diabetes Sci Technol (2008) 0.88
Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitus. J Diabetes Sci Technol (2010) 0.88
Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same? J Diabetes Sci Technol (2011) 0.88
Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin. Anal Chem (2013) 0.87
A rapid and fully-automated method for the quantitation of tricyclic antidepressants in serum using turbulent-flow liquid chromatography-tandem mass spectrometry. Clin Chim Acta (2010) 0.87
Clinical consequences of analytical variance and calculation strategy in oral busulfan pharmacokinetics. Clin Chim Acta (2011) 0.87
Usefulness of cystatin C and prognosis following admission for acute heart failure. Am J Cardiol (2009) 0.87
Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol (2013) 0.87
Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. Clin Biochem (2008) 0.86
Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial. PLoS One (2011) 0.84
Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta (2010) 0.84
Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr (2015) 0.84
Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. Diabetes Technol Ther (2013) 0.83
A survey of occupational therapists in Canada about their knowledge and use of the ICF. Can J Occup Ther (2007) 0.83
Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study. Diabetes Metab Res Rev (2005) 0.83
Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes. Diabetes Technol Ther (2009) 0.83
Therapeutic drug monitoring in cancer chemotherapy. Bioanalysis (2010) 0.83
System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. Diabetes Technol Ther (2013) 0.83
Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes. Methods Enzymol (2009) 0.82
A rapid and reliable semiautomated method for measurement of total abdominal fat volumes using magnetic resonance imaging. Magn Reson Imaging (2003) 0.82
Clinical assessment and mathematical modeling of the accuracy of continuous glucose sensors (CGS). Conf Proc IEEE Eng Med Biol Soc (2006) 0.82
Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung (2007) 0.82
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol (2009) 0.82
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS One (2012) 0.82
Effects of acute inhalation of aerosols generated during resistance spot welding with mild-steel on pulmonary, vascular and immune responses in rats. Inhal Toxicol (2014) 0.81
Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes. Diabetes Technol Ther (2004) 0.81